Have you registered for BioProcess International in Boston on September 10-12, 2019? Schedule a Meeting with the link below and learn more about Cytovance® Biologics and our growing list of capabilities. hubs.ly/H0krMgv0

Cytovance's CTO, Dr. Jesse McCool, to speak at Boston’s BioProcess International Convention on 9/11 at 2:45 pm. Cytovance will be exhibiting at booth #630. Cytovance® Biologics is a leading biologic CDMO. hubs.ly/H0kwPsZ0. #BPIconf

Are you attending BioProcess International in Boston next week? Schedule a meeting with the link below to your discuss current or upcoming projects. hubs.ly/H0kty6x0 #BPIconf #cytovancebio

At Biotech week in Boston? Don't miss Jesse McCool, Cytovance's CTO presenting on "Developing Phase Appropriate GMPs Systems" this Wednesday at 2:45pm, Technology Workshops, room 210A. #BPIconf hubs.ly/H0ktzzv0

Come see Cytovance Biologics this Thursday 9/26 at Contract Pharma's Outsourcing Conference at the Hyatt Regency, New Brunswick, NJ. Cytovance® places a significant focus on customer experience and work hard to ensure a culture of quality, flexibility, speed, and reliability.

Come hear Cytovance's own Mike O'Mara, SVP of Manufacturing Operations give a talk on “Gene Therapy Supply Chain, Meeting the Demand" at the Gene Therapy for Rare Disorders Conference on Wed, Oct 16 at the Hyatt Regency London - The Churchill, London. #genetherapy #CDMONews

Cytovance's own Christa Short talk on "High cell density perfusion for the production of AAV2 viral vectors using the Repligen XCell™ ATF system" at the bioprocessing seminar on 10/17, 9:45 am at the SF Marriott Waterfront Hotel. hubs.ly/H0lcRWl0 #genetherapy #CDMONews

One of Cytovance’s core services is recombinant protein drug substance production derived from mammalian cell culture. Read more about it at hubs.ly/H0ljhQL0

PRESS RELEASE: Cytovance® Biologics Introduces an Integrated Single-use Platform for Plasmid DNA Manufacture. Cytovance® Biologics announced today the addition of a new integrated single-use platform...hubs.ly/H0ll4tC0 #pDNA #genetherapy #plasmidDNA #CDMONews

#PlasmidDNA Manufacturing Market Update: Cytovance Biologics Introduces Integrated Single-Use Platform. rootsanalysis.com/blog/2019/10/2…

Member news: Cytovance Biologics Introduces an Integrated Single-use Platform for Plasmid DNA (pDNA) Manufacture globenewswire.com/news-release/2…

We Are Now Offering Three Grades of pDNA Vectors to Our Clients! Need pDNA vectors for your project? Is your project for pre-clinical, clinical or commercial? We’ve got you covered. hubs.ly/H0lsM4T0 or contact us at [email protected] #pDNA #genetherapy #plasmidDNA

All of our manufacturing and support operations are built on the framework of a comprehensive quality management system. Read more at hubs.ly/H0lzJ150

This #VeteransDay, we'd like to extend our thanks and gratitude for all who served. Thank you! 🇺🇸

Cytovance knows that advanced facilities and production processes can themselves only be truly optimized by proactive Program Management focused on quality production in the shortest time possible. hubs.ly/H0lzG3L0

Our R&D Services include cell line development, microbial strain selection, cell culture development, and more! See how else we can help at hubs.ly/H0lzHpM0

Are you attending Antibody Engineering & Therapeutics Conference at the Marriott Marquis, San Diego, CA 12/9-13? Come by our booth #418 to discuss current or upcoming projects. We excel in development and manufacture of mammalian cell culture and microbial fermentation.

The Staff at Cytovance Biologics wishes you all a very Happy Turkey Day!

Cytovance will be at booth #418 at the Antibody Engineering & Therapeutics Conference at the Marriott Marquis, in SD, CA 12/9-13. We excel in rapid and cost-effective development and manufacture of biologics from both mammalian cell culture and microbial fermentation.

Cytovance will be at booth #418 at the Antibody Engineering & Therapeutics Conference at the Marriott Marquis this week in San Diego, CA. We excel in rapid and cost-effective development and manufacture of Biologics from both mammalian cell culture and microbial fermentation.